{
    "eu_pnumber": "__SCRAPER_NOT_FOUND__",
    "atc_code": "__SCRAPER_NOT_FOUND__",
    "eu_aut_status": "ACTIVE",
    "eu_brand_name_current": "EU/3/00/005",
    "status_type": "a",
    "eu_od_number": "EU/3/00/005",
    "active_substance": "Gemtuzumab Ozogamicin",
    "eu_od_con": "Treatment of acute myeloid leukaemia",
    "eu_od_sponsor": "Pfizer Europe MA EEIG",
    "eu_od_pnumber": "EU/1/18/1277",
    "orphan_status": "o",
    "eu_od_date": "2000-10-18 00:00:00",
    "eu_aut_date": "2000-10-18 00:00:00",
    "eu_aut_type_initial": "attribute not available on release",
    "eu_aut_type_current": "standard",
    "ema_od_number": "EMEA/OD/022/00",
    "ema_number_id": "22/00",
    "eu_referral": "False",
    "eu_suspension": "False",
    "ema_number_certainty": "0.75",
    "authorisation_row": "0",
    "scrape_date_web": "20/12/2022",
    "filedates": {
        "EU-3-00-005_o_dec_0.pdf": {
            "pdf_link": "https://ec.europa.eu/health/documents/community-register/2000/200010185296/dec_5296_en.pdf",
            "pdf_date": "2000-10-18 00:00:00",
            "pdf_scrape_date": "2022-12-21 11:38:00.275459"
        },
        "EU-3-00-005_o_dec_1.pdf": {
            "pdf_link": "https://ec.europa.eu/health/documents/community-register/2013/20130315125746/dec_125746_en.pdf",
            "pdf_date": "2013-03-15 00:00:00",
            "pdf_scrape_date": "2022-12-21 11:38:00.275459"
        },
        "EU-3-00-005_o_dec_2.pdf": {
            "pdf_link": "https://ec.europa.eu/health/documents/community-register/2018/20180725141595/dec_141595_en.pdf",
            "pdf_date": "2018-07-25 00:00:00",
            "pdf_scrape_date": "2022-12-21 11:38:00.275459"
        },
        "EU-3-00-005_o_public-assessment-report.pdf": {
            "pdf_link": "https://www.ema.europa.eu/documents/assessment-report/mylotarg-epar-public-assessment-report_en.pdf",
            "pdf_date": "2022-12-21 11:38:00.275459",
            "pdf_scrape_date": "2022-12-21 11:38:00.275459"
        },
        "EU-3-00-005_o_omar.pdf": {
            "pdf_link": "https://www.ema.europa.eu/documents/orphan-maintenance-report/mylotarg-orphan-maintenance-assessment-report-initial-authorisation_en.pdf",
            "pdf_date": "2022-12-21 11:38:00.275459",
            "pdf_scrape_date": "2022-12-21 11:38:00.275459"
        },
        "EU-3-00-005_o_epar-other_0.pdf": {
            "pdf_link": "https://www.ema.europa.eu/documents/procedural-steps-after/mylotarg-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf",
            "pdf_date": "2022-12-21 11:38:00.275459",
            "pdf_scrape_date": "2022-12-21 11:38:00.275459"
        },
        "EU-3-00-005_o_epar-other_1.pdf": {
            "pdf_link": "https://www.ema.europa.eu/documents/variation-report/mylotarg-h-c-4204-ii-0007-epar-assessment-report-variation_en.pdf",
            "pdf_date": "2022-12-21 11:38:00.276436",
            "pdf_scrape_date": "2022-12-21 11:38:00.276436"
        },
        "EU-3-00-005_o_epar-other_2.pdf": {
            "pdf_link": "https://www.ema.europa.eu/documents/variation-report/mylotarg-h-c-4204-p46-003-epar-assessment-report_en.pdf",
            "pdf_date": "2022-12-21 11:38:00.276436",
            "pdf_scrape_date": "2022-12-21 11:38:00.276436"
        }
    }
}